secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRADIMED CORP (IRMD)
CIK:        0001325618
Form:       8-K
Filed at:   2021-07-12T23:59:59+00:00
Accession:  0000898432-21-000566
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iradimed promotes Chris Scott to CFO and COO with new employment agreement
--------------------------------------------------------------------------

- Chris Scott appointed Chief Financial and Operating Officer effective July 8, 2021.
- Base salary of $360,000/year; annual bonus target 60% of salary.
- Immediate RSU grant of $150,000 vesting over four years.
- Annual equity target of $400,000 under incentive plan.
- Severance: 12 months base salary for without cause/good reason; 18 months for change in control.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1325618/000089843221000566/0000898432-21-000566-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1325618/000089843221000566/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0000898432-21-000566

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer